id: maud_access_to_all_cause_mortality_cirrhosis
name: Access to Medications for Alcohol Use Disorder (MAUD) â†’ All-Cause Mortality
  in Alcohol-Associated Cirrhosis
from_node:
  node_id: maud_access
  node_name: Access to Medications for Alcohol Use Disorder (MAUD)
to_node:
  node_id: all_cause_mortality_cirrhosis
  node_name: All-Cause Mortality in Alcohol-Associated Cirrhosis
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: MAUD (naltrexone or acamprosate) prescribed to patients with alcohol-associated
  cirrhosis and high-risk alcohol use disorder'
- 'Step 2: Medications achieve and maintain abstinence or reduced alcohol consumption
  in patients with AUD'
- 'Step 3: Reduced alcohol consumption prevents progression of liver disease and cirrhosis
  decompensation'
- 'Step 4: Prevention of cirrhosis progression and decompensation reduces mortality
  risk'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: A. Rabiee et al. 2023. "Medications for alcohol use disorder improve
    survival in patients with hazardous drinking and alcohol-associated cirrhosis."
    *Hepatology Communications*. https://doi.org/10.1097/HC9.0000000000000093
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.335060'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: duration_maud_exposure
  direction: strengthens
  strength: moderate
  description: Duration of MAUD exposure >3 months in 39% of exposed patients suggests
    longer exposure may provide greater benefit
- name: cirrhosis_decompensation_history
  direction: weakens
  strength: strong
  description: History of cirrhosis decompensation was the strongest negative predictor
    of MAUD prescription, indicating structural barriers to accessing treatment for
    sicker patients
- name: inpatient_aud_diagnosis
  direction: strengthens
  strength: strong
  description: Inpatient diagnosis code for AUD was the strongest positive predictor
    of MAUD prescription, suggesting hospitalization increases treatment access
- name: concurrent_depression_diagnosis
  direction: strengthens
  strength: moderate
  description: Concurrent diagnosis of depression was a positive predictor of MAUD
    prescription, possibly reflecting greater engagement with mental health services
